Latest Insider Transactions at Optimize Rx Corp (OPRX)
This section provides a real-time view of insider transactions for Optimize Rx Corp (OPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OptimizeRx Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OptimizeRx Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.47%
|
-
|
|
Dec 31
2020
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+1.24%
|
-
|
|
Dec 31
2020
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+3.61%
|
-
|
|
Dec 31
2020
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.45%
|
-
|
|
Dec 31
2020
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+4.51%
|
-
|
|
Dec 31
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,186
+6.74%
|
-
|
|
Nov 12
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.19%
|
$30,000
$2.46 P/Share
|
|
Nov 11
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-16.54%
|
$360,000
$24.05 P/Share
|
|
Sep 30
2020
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+3.69%
|
-
|
|
Sep 30
2020
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+1.84%
|
-
|
|
Sep 30
2020
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+5.43%
|
-
|
|
Sep 30
2020
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+3.66%
|
-
|
|
Sep 30
2020
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+6.81%
|
-
|
|
Sep 30
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,186
+7.22%
|
-
|
|
Mar 31
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,187
+7.79%
|
-
|
|
May 14
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,874
-1.14%
|
$557,362
$13.61 P/Share
|
|
May 13
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,126
-0.56%
|
$92,638
$13.72 P/Share
|
|
May 10
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-1.93%
|
$325,000
$13.76 P/Share
|
|
May 09
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-3.71%
|
$650,000
$13.57 P/Share
|
|
Mar 18
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,760
-0.57%
|
$116,400
$15.15 P/Share
|
|
Mar 15
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,637
-1.0%
|
$204,555
$15.0 P/Share
|